HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
EW
Edwards Lifesciences Corp
Healthcare Medical Devices · California, USA · Reports in usd
Market Cap: $47.93B
Market Cap
$47.93B
Enterprise Val
$44.96B
P/E Ratio
43.72
P/B Ratio
4.64
Trailing PEG (1Y)
5.33
As Of
Jul 23, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$10.33B
Gross Margin78.01%
Profit Margin78.01%
Return on Equity10.59%
Return on Assets8.15%
Current Ratio4.42
Debt/Equity0.07
LT Debt/Equity0.07
Revenue Per Share2.84

Income Statement

Mar 31, 2026
Revenue$1.65B
Cost of Revenue$362.6M
Gross Profit$1.29B
R&D$263.3M
SG&A$522.2M
Operating Expenses$932.0M
Operating Income$354.0M
Interest Expense$0.00
Tax Expense$78.3M
Net Income$380.7M
EPS (Basic)$0.66
EPS (Diluted)$0.66
EBIT$459.0M
EBITDA$506.4M
Consolidated Income$380.7M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$2.45B
Accounts Receivable$973.0M
Inventory$1.12B
Current Assets$6.23B
LT Investments$285.6M
Property, Plant & Equipment$1.92B
Intangibles$3.05B
Non-Current Assets$7.09B
Total Assets$13.32B
Accounts Payable$1.38B
Current Debt$24.3M
Current Liabilities$1.41B
LT Debt$678.6M
Non-Current Liabilities$1.58B
Total Liabilities$2.99B
Total Debt$702.9M
Retained Earnings$14.62B
Shareholder Equity$10.33B
Shares Outstanding580,000,000

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow$43.8M
Investing Cash Flow-$92.8M
Financing Cash Flow-$451.2M
CapEx-$64.9M
Free Cash Flow-$21.1M
Depreciation & Amort.$47.4M
Stock-Based Comp$45.4M
Acquisitions / Disposals-$41.4M
Investment Activity$13.8M
Debt Issued/Repaid$0.00
Equity Issued/Repaid-$352.9M
Dividends Paid$0.00
Net Change in Cash-$492.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h